These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9069478)

  • 61. Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging.
    O'Brien FM; Page L; O'Gorman RL; Bolton P; Sharma A; Baird G; Daly E; Hallahan B; Conroy RM; Foy C; Curran S; Robertson D; Murphy KC; Murphy DG
    Psychiatry Res; 2010 Nov; 184(2):77-85. PubMed ID: 20952166
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurotensin receptors in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study in basal ganglia.
    Chinaglia G; Probst A; Palacios JM
    Neuroscience; 1990; 39(2):351-60. PubMed ID: 1965015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.
    Zhou B; Yuan F; He Z; Tan C
    Brain Imaging Behav; 2014 Mar; 8(1):97-101. PubMed ID: 23955491
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder.
    Ohara K; Isoda H; Suzuki Y; Takehara Y; Ochiai M; Takeda H; Igarashi Y; Ohara K
    Psychiatry Res; 1999 Dec; 92(2-3):83-91. PubMed ID: 10674362
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen.
    Scherk H; Backens M; Schneider-Axmann T; Kraft S; Kemmer C; Usher J; Reith W; Falkai P; Meyer J; Gruber O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):524-30. PubMed ID: 17965994
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders.
    Hamakawa H; Kato T; Murashita J; Kato N
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(1):53-8. PubMed ID: 9561353
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid.
    Dautry C; Condé F; Brouillet E; Mittoux V; Beal MF; Bloch G; Hantraye P
    Neurobiol Dis; 1999 Aug; 6(4):259-68. PubMed ID: 10448053
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy.
    Hardman CD; Halliday GM; McRitchie DA; Morris JG
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):132-42. PubMed ID: 9034366
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder.
    Scherk H; Backens M; Schneider-Axmann T; Kemmer C; Usher J; Reith W; Falkai P; Gruber O
    Acta Psychiatr Scand; 2008 Apr; 117(4):283-8. PubMed ID: 18205896
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.
    Simone IL; Federico F; Tortorella C; Andreula CF; Zimatore GB; Giannini P; Angarano G; Lucivero V; Picciola P; Carrara D; Bellacosa A; Livrea P
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):516-23. PubMed ID: 9576546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes.
    Clarke CE; Lowry M
    Eur J Neurol; 2001 Nov; 8(6):573-7. PubMed ID: 11784341
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thalamic proton magnetic resonance spectroscopy in vegetative state induced by traumatic brain injury.
    Uzan M; Albayram S; Dashti SG; Aydin S; Hanci M; Kuday C
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):33-8. PubMed ID: 12486263
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multivoxel proton magnetic resonance spectroscopy in heat stroke.
    Li J; Zhang XY; Wang B; Zou ZM; Li HF; Wang PY; Xia JK
    Clin Radiol; 2015 Jan; 70(1):37-41. PubMed ID: 25443777
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.
    Brambilla P; Stanley JA; Nicoletti MA; Sassi RB; Mallinger AG; Frank E; Kupfer D; Keshavan MS; Soares JC
    J Affect Disord; 2005 May; 86(1):61-7. PubMed ID: 15820271
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neural damage in the lenticular nucleus linked with tardive dyskinesia in schizophrenia: a preliminary study using proton magnetic resonance spectroscopy.
    Ando K; Takei N; Matsumoto H; Iyo M; Isoda H; Mori N
    Schizophr Res; 2002 Oct; 57(2-3):273-9. PubMed ID: 12223259
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
    Qiu SJ; Zhang XL; Zhang Y; Jiang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.